Laurion Capital Management LP Gilead Sciences, Inc. Transaction History

Laurion Capital Management LP

$7.27 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $342,336 - $395,082	5,421 New	5,421 $371,000
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $7.92 Million - $8.98 Million	108,096 New	108,096 $8.76 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $461,772 - $526,101	5,973 New	5,973 $495,000
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $483,693 - $544,783	-8,380 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $207,353 - $259,836	3,580 Added 74.58%	8,380 $498,000
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $661,776 - $751,128	-10,200 Reduced 68.0%	4,800 $348,000
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $1.02 Million - $1.1 Million	15,000 New	15,000 $1.05 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $1.11 Million - $1.26 Million	-18,442 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $1.04 Million - $1.19 Million	18,442 New	18,442 $1.07 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $206,420 - $259,537	-3,324 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $240,458 - $279,216	3,324 New	3,324 $256,000
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $1.33 Million - $1.7 Million	-21,246 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $10.6 Million - $11.7 Million	-171,949 Reduced 89.0%	21,246 $1.38 Million
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $12 Million - $13.3 Million	192,395 Added 24049.38%	193,195 $12.2 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $49,496 - $55,504	800 New	800 $54,000
Q1 2019 May 08, 2019	SELL	$62.53 - $70.05 $6.35 Million - $7.12 Million	-101,572 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $6.11 Million - $7.97 Million	100,934 Added 15820.38%	101,572 $6.35 Million
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $599,491 - $699,283	-9,240 Reduced 93.54%	638 $45,000
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $719,513 - $877,166	9,878 New	9,878 $745,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Account